Abfero Pharmaceuticals, Inc
AbFero Pharmaceuticals is a privately-held clinical stage pharmaceutical company dedicated to treating diseases of iron overload. Our therapeutic platform addresses transfusion-related iron overload (TIO) and iron accumulation associated with diseases of aging, such as age-related macular degeneration (AMD), and Parkinson’s disease. AbFero has completed three clinical trials with the company’s lead iron chelator, SP-420. AbFero Pharmaceuticals, Inc, is based in Boston, Massachusetts, and our subsidiary, AbFero, Ltd, is located in Harwell, UK.
7-day free trial · no credit card
Verified contacts
1
available on Kipplo
LinkedIn employees
2
1 to 10 range
Open roles
—
no listings
Distinct roles
1
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 1 verified contacts at Abfero Pharmaceuticals, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
1 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Abfero Pharmaceuticals, Inc
1 distinct titles indexed · top 1 shown.
- 1ingénieur logiciels
Sign up to unlock all 1 contacts at Abfero Pharmaceuticals, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 1 verified contacts at Abfero Pharmaceuticals, Inc
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.